Circulating immune complexes in pediatric renal allograft rejection

Area of Science:

• Nephrology
• Immunology
• Transplantation

Background:

• Conflicting reports exist regarding the role of post-transplant circulating immune complexes (CICs) in kidney allograft rejection.
• Understanding the pathogenicity of CICs is crucial for managing acute rejection (AR) and improving transplant outcomes.

Purpose of the Study:

• To evaluate the pathogenic role of CICs in pediatric renal allograft recipients experiencing acute rejection.
• To determine if CIC levels correlate with AR episodes or ultimate allograft outcome.

Main Methods:

• Utilized C1q-solid phase assay (C1q-SPA) and Raji cell radioimmunoassay (Raji-RIA) for 784 CIC determinations on 392 serum samples from 27 pediatric renal allograft recipients.
• Compared CIC levels in patients with AR against controls (non-rejection episodes and normal subjects).
• Performed histological and immunofluorescent studies on allograft biopsies; employed sucrose density gradient ultracentrifugation.

Main Results:

• Over 92% of CIC determinations were negative; CICs were present post-transplant in only 19.6% of recipients.
• Statistical analysis (chi-squared test) revealed no significant correlation between CIC levels and AR episodes.
• Immunofluorescence and histology did not show significant immunoglobulin or complement deposition; no evidence linked antithymocyte globulin (ATG) as an immunogen.

Conclusions:

• Circulating immune complexes (CICs) do not appear to be a significant mediator of acute rejection (AR) in pediatric renal allograft recipients.
• CIC levels did not correlate with AR or the ultimate outcome of the allograft.
• Further research may be needed to identify other key factors in renal allograft rejection.